BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAHPRA - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAHPRA
X-ORIGINAL-URL:https://www.sahpra.org.za
X-WR-CALDESC:Events for SAHPRA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20150101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20211110T100000
DTEND;TZID=Africa/Johannesburg:20211110T113000
DTSTAMP:20260425T134236
CREATED:20211108T112557Z
LAST-MODIFIED:20211108T112557Z
UID:9416-1636538400-1636543800@www.sahpra.org.za
SUMMARY:Mitigating COVID-19 Vaccine Hesitancy in South Africa
DESCRIPTION:
URL:https://www.sahpra.org.za/event/mitigating-covid-19-vaccine-hesitancy-in-south-africa/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.sahpra.org.za/wp-content/uploads/2021/11/Mitigating-COVID-19-Vaccine-Hesitancy-in-South-Africa-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20211109T123000
DTEND;TZID=Africa/Johannesburg:20211109T133000
DTSTAMP:20260425T134236
CREATED:20211109T144142Z
LAST-MODIFIED:20211109T144405Z
UID:9436-1636461000-1636464600@www.sahpra.org.za
SUMMARY:Enhancing the public trust in COVID-19 vaccination
DESCRIPTION:Enhancing the public trust in COVID-19 vaccination: Progress and challenges in the regulation\, administration and rollout of vaccines in South Africa. \nThe race for countries to reach herd immunity continues globally. The prolonged Covid-19 pandemic has adversely affected the social and economic standing of many nations and South Africa is no exception. While vaccines bring a glimpse of hope the reality remains\, that the successful administration and rollout of Covid-19 vaccines is largely dependent on the enhanced public trust of the vaccines and related institutions. It is also appreciated that the rise of vaccine-related conspiracy theories and myths counter noble global efforts in fighting the Covid-19 Pandemic. \nScifest Africa hosted a  webinar that explored the progress and challenges related to the regulation\, administration and rollout of Covid-19 Vaccines in South Africa. \nThe discussion tackled the role of enhanced public trust in attaining vaccination goals as set by the government. The webinar will also investigate the projected impact of Covid-19 vaccine passports in accelerating vaccination for the South African population. \n\nWatch the video below:
URL:https://www.sahpra.org.za/event/enhancing-the-public-trust-in-covid-19-vaccination/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.sahpra.org.za/wp-content/uploads/2021/11/Scifest-Nov-2021-3-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20210913T110000
DTEND;TZID=Africa/Johannesburg:20210913T123000
DTSTAMP:20260425T134236
CREATED:20210913T135828Z
LAST-MODIFIED:20211026T081720Z
UID:9353-1631530800-1631536200@www.sahpra.org.za
SUMMARY:Self-reporting suspected adverse drug reactions (ADRs) of medicines and vaccines webinar
DESCRIPTION:In February 2021\, South Africa’s National Department of Health (NDoH) embarked on a nationwide COVID-19 vaccine rollout plan. The phased approach to immunisation ramped up in July 2021\, with a record number of individuals (over a million in a single day) registering for their doses. \n 
URL:https://www.sahpra.org.za/event/self-reporting-suspected-adverse-drug-reactions-adrs-of-medicines-and-vaccines-webinar/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.sahpra.org.za/wp-content/uploads/2021/09/Self-reporting-suspected-adverse-drug-reactions-ADRs-of-medicines-and-vaccines-2048x1147-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20210820T140000
DTEND;TZID=Africa/Johannesburg:20210820T160000
DTSTAMP:20260425T134236
CREATED:20210920T071956Z
LAST-MODIFIED:20211026T080604Z
UID:9181-1629468000-1629475200@www.sahpra.org.za
SUMMARY:AEFI reporting microsite media briefing webinar
DESCRIPTION:The South African Health Products Regulatory Authority (SAHPRA)\, invites you to the launch of the Adverse Events Following Immunisation (AEFI) reporting microsite. \nThe microsite will keep the public updated on reports of adverse events following immunisation (AEFIs) associated with COVID-19 vaccine administration. All medicines\, including vaccines\, can cause side effects. In the case of vaccines\, side effects or adverse events that occur after vaccine administration are known as AEFIs. However\, the benefits of COVID-19 vaccination outweigh the risks. COVID-19 vaccines have proven to prevent severe forms of disease\, hospitalisation and death. \nWatch the webinar below: \n
URL:https://www.sahpra.org.za/event/aefi-reporting-microsite-media-briefing-webinar/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.sahpra.org.za/wp-content/uploads/2021/09/AEFI-reporting-microsite-banner-2048x784-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20210701T100000
DTEND;TZID=Africa/Johannesburg:20210701T110000
DTSTAMP:20260425T134236
CREATED:20210920T073310Z
LAST-MODIFIED:20211026T080658Z
UID:9186-1625133600-1625137200@www.sahpra.org.za
SUMMARY:SAHPRA COVID19 Response Webinar
DESCRIPTION:SAHPRA and PATH hosted a webinar panel discussion on the coordinated introduction of COVD19 vaccines and tools and the important role of the South African Health Products Regulatory Authority (SAHPRA) and the National Department of Health in COVID19 vaccine planning and roll-out whilst ensuring equitable access and safety for all South Africans. \nWatch the webinar below: \n
URL:https://www.sahpra.org.za/event/sahpra-covid19-response-webinar/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.sahpra.org.za/wp-content/uploads/2021/09/image003.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20210624T100000
DTEND;TZID=Africa/Johannesburg:20210624T110000
DTSTAMP:20260425T134236
CREATED:20210920T071448Z
LAST-MODIFIED:20210920T071448Z
UID:9354-1624528800-1624532400@www.sahpra.org.za
SUMMARY:The Process of Vaccine Approval webinar
DESCRIPTION:The normal process for the evaluation of a vaccine necessitates that all the required information regarding product safety\, efficacy and quality be provided at the time of submission. In other words\, all the clinical trial data for safety and efficacy from phase one to three should be provided together with manufacturing information of the product quality. \nIn an effort to respond to the pandemic\, SAHPRA introduced another mechanism to facilitate the review of COVID-19 applications\, which is the rolling review process. The rolling review is a mechanism that facilitates the submission of data as it becomes available. This webinar will focus on the vaccine approval processes. \nWatch the webinar below: \n
URL:https://www.sahpra.org.za/event/the-process-of-vaccine-approval-webinar/
CATEGORIES:Webinar
ATTACH;FMTTYPE=:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20161119T090000
DTEND;TZID=Africa/Johannesburg:20161119T160000
DTSTAMP:20260425T134236
CREATED:20220712T075319Z
LAST-MODIFIED:20220712T075319Z
UID:11414-1479546000-1479571200@www.sahpra.org.za
SUMMARY:eCTD Go-live in South Africa
DESCRIPTION:The Medicines Control Council (MCC) went live with eCTD for New Chemical Entities on 01 April 2016\, and the intended go-live date for generic applications is 02 January 2017. \nFind out more
URL:https://www.sahpra.org.za/event/ectd-go-live-in-south-africa/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://www.sahpra.org.za/wp-content/uploads/2022/07/ectd.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20160705T090000
DTEND;TZID=Africa/Johannesburg:20160710T170000
DTSTAMP:20260425T134236
CREATED:20220712T081846Z
LAST-MODIFIED:20220712T082034Z
UID:11417-1467709200-1468170000@www.sahpra.org.za
SUMMARY:Immunogenicity of Biopharmaceuticals workshop
DESCRIPTION:The International Council for Harmonisation (ICH) met in Osaka\, Japan on 5-10 November 2016. As part of the objective to extend its global outreach\, ICH is pleased to welcome the Agência Nacional de Vigilância Sanitária (ANVISA) from Brazil and the Ministry of Food and Drug Safety (MFDS) from South Korea as the first new regulatory Members\, together with the Biotechnology Innovation Organization (BIO) as a new industry association Member. \nFind out more
URL:https://www.sahpra.org.za/event/immunogenicity-of-biopharmaceuticals-workshop/
LOCATION:Osaka\, Japan\, Japan
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/jpeg:https://www.sahpra.org.za/wp-content/uploads/2022/07/conference-01-1.jpeg
END:VEVENT
END:VCALENDAR